Related Experiment Videos
The role of RBC transfusion in the premature infant
Insights
Routine red blood cell (RBC) transfusions do not benefit premature infants. This study found no clinical advantage in keeping hemoglobin levels above 10.0 g/dL for growing premature infants.
Area of Science:
- Neonatology
- Pediatric Hematology
- Critical Care Medicine
Background:
- Premature infants often require red blood cell (RBC) transfusions due to anemia.
- Current transfusion guidelines vary, with some advocating for higher hemoglobin thresholds.
Purpose of the Study:
- To evaluate the clinical efficacy of maintaining a higher hemoglobin threshold (above 10.0 g/dL) versus transfusing only for clinical indications in premature infants.
Main Methods:
- Randomized controlled trial involving 56 premature infants (mean gestational age 30 weeks).
- Two groups: transfusion group (hemoglobin > 10.0 g/dL) and nontransfusion group (transfused for clinical indications).
- Longitudinal follow-up included weekly laboratory tests and assessments of clinical outcomes.
Main Results:
- No significant differences in birth weight, gestational age, or initial hemoglobin levels between groups.
- Laboratory differences were observed at discharge, but no significant clinical differences were found.
- No clinical advantage was identified for routine "booster" RBC transfusions.
Conclusions:
- Maintaining a hemoglobin level above 10.0 g/dL through routine transfusions offers no discernible clinical benefit for growing premature infants compared to transfusing based on clinical need.
- These findings suggest that current transfusion practices for premature infants may not require adjustment to higher hemoglobin thresholds.
Abstract:
Fifty-six premature infants with a mean gestational age at birth of 30 weeks were randomly assigned to a transfusion group, for whom the hemoglobin level was kept above 10.0 g/dL, and a nontransfusion group, who were transfused only for specific clinical indications. The groups were followed up longitudinally with weekly determinations of reticulocyte count, the partial pressure of oxygen at which 50% of hemoglobin is saturated, and hemoglobin F percentage, as well as weight gain, length of stay, hospital cost, and frequency and severity of apnea. At birth, there was no significant difference in birth weight, gestational age, and hemoglobin level between the two groups. At discharge, laboratory differences were noted between the two groups, but there was no clinical difference. We found no clinical advantage to the use of "booster" RBC transfusions in growing premature infants.